Peijia Medical Limited (F:4WO) — Market Cap & Net Worth
Market Cap & Net Worth: Peijia Medical Limited (4WO)
Peijia Medical Limited (F:4WO) has a market capitalization of $401.71 Million (€343.60 Million) as of September 20, 2026. Listed on the F stock exchange, this Germany-based company holds position #13493 globally and #1396 in its home market, demonstrating a 1.98% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Peijia Medical Limited's stock price €0.52 by its total outstanding shares 669511953 (669.51 Million). Also see Peijia Medical Limited (4WO) total assets for a full breakdown of the balance sheet.
Peijia Medical Limited Market Cap History: 2020 to 2026
Peijia Medical Limited's market capitalization history from 2020 to 2026. Data shows change from $2.24 Billion to $403.11 Million (-24.31% CAGR). Also see cash efficiency ratio of Peijia Medical Limited for how efficiently the company converts equity into cash flow.
Peijia Medical Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Peijia Medical Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Peijia Medical Limited (4WO) share price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.71x
Peijia Medical Limited's market cap is 0.71 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $2.24 Billion | $38.66 Million | -$2.07 Billion | 57.91x | N/A |
| 2021 | $1.06 Billion | $136.53 Million | -$574.22 Million | 7.80x | N/A |
| 2022 | $861.00 Million | $250.83 Million | -$407.81 Million | 3.43x | N/A |
| 2023 | $700.54 Million | $441.13 Million | -$392.52 Million | 1.59x | N/A |
| 2024 | $372.58 Million | $615.48 Million | -$226.58 Million | 0.61x | N/A |
| 2025 | $508.77 Million | $712.87 Million | -$203.29 Million | 0.71x | N/A |
Competitor Companies of 4WO by Market Capitalization
Companies near Peijia Medical Limited in the global market cap rankings as of September 20, 2026. Review 4WO tangible net worth ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Peijia Medical Limited by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #124 globally with a market cap of $178.43 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #228 globally with a market cap of $109.30 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #238 globally with a market cap of $105.53 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #240 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #124 | Abbott Laboratories | NYSE:ABT | $178.43 Billion | $102.61 |
| #228 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $92.13 |
| #238 | Stryker Corporation | NYSE:SYK | $105.53 Billion | $275.12 |
| #240 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Peijia Medical Limited Historical Marketcap From 2020 to 2026
Between 2020 and today, Peijia Medical Limited's market cap moved from $2.24 Billion to $ 403.11 Million, with a yearly change of -24.31%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €403.11 Million | -20.77% |
| 2025 | €508.77 Million | +36.55% |
| 2024 | €372.58 Million | -46.82% |
| 2023 | €700.54 Million | -18.64% |
| 2022 | €861.00 Million | -19.12% |
| 2021 | €1.06 Billion | -52.45% |
| 2020 | €2.24 Billion | -- |
End of Day Market Cap According to Different Sources
On Sep 19th, 2026 the market cap of Peijia Medical Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $401.71 Million USD |
| MoneyControl | $401.71 Million USD |
| MarketWatch | $401.71 Million USD |
| marketcap.company | $401.71 Million USD |
| Reuters | $401.71 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Peijia Medical Limited
Peijia Medical Limited, together with its subsidiaries, engages in the research, development, manufacturing, and sales of transcatheter valve therapeutic and neurointerventional procedural medical devices in the People's Republic of China. It operates through Transcatheter Valve Therapeutic Business, Neurointerventional Business, and Future Technology Business segments. The company's products inc… Read more